Diagnosis and treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Dr. Claudio Cerchione, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy, was so kind to give us an update on the diagnosis and treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare malignant disease with rapid systemic spread. He highlights the importance of the multidisciplinary team in recognising symptoms to make a correct diagnosis and is hopeful with tagraxofusp as new treatment option for this malignancy.
With the educational support of:
